Format

Send to:

Choose Destination
See comment in PubMed Commons below
Osteoarthritis Cartilage. 2014 Jun;22(6):742-6. doi: 10.1016/j.joca.2014.03.015. Epub 2014 Mar 29.

Factors associated with arthrogenous muscle inhibition in patellofemoral osteoarthritis.

Author information

  • 1Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, University of Manchester, Oxford Road, Manchester, UK. Electronic address: michael.callaghan@manchester.ac.uk.
  • 2Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, University of Manchester, Oxford Road, Manchester, UK. Electronic address: matthew.parkes@manchester.ac.uk.
  • 3Warwick Medical School, The University of Warwick, Coventry, UK. Electronic address: c.e.hutchinson@warwick.ac.uk.
  • 4Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, University of Manchester, Oxford Road, Manchester, UK; NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Sciences Centre, Manchester, UK; Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, USA. Electronic address: david.felson@manchester.ac.uk.

Abstract

OBJECTIVES:

Arthrogenous muscle inhibition (AMI) is thought to contribute to quadriceps weakness in knee osteoarthritis (OA), but its relationship with structural changes of bone marrow lesions (BMLs), capsular distension and pain is unclear. This study's objective was to investigate the factors associated with AMI in subjects with symptomatic patellofemoral joint OA (PFJOA).

DESIGN:

126 Subjects with predominant PFJOA were assessed for pain by the visual analogue scale (VAS) for a nominated aggravating activity. Their more symptomatic knee underwent a magnetic resonance imaging (MRI) scan which was used to assess BMLs and synovitis which were scored using the Whole Organ MRI score (WORMS). Quadriceps AMI was measured by calculating the activation deficit and quadriceps strength assessed by isometric maximum voluntary contraction. Multiple linear regressions were used to assess factors associated with AMI.

RESULTS:

We studied 124 subjects [mean age 55.5 (SD 7.5); 57.14% female]. In regression analyses, higher levels of AMI were significantly associated with more severe knee pain and with lower BML score.

CONCLUSION:

Quadriceps AMI in knee OA is associated with severity of knee pain and surprisingly with lower BML scores.

Copyright © 2014. Published by Elsevier Ltd.

KEYWORDS:

Arthrogenous muscle inhibition; Bone marrow lesions; Knee; MRI; Osteoarthritis; Quadriceps

PMID:
24685526
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk